酒精相关肝炎的新兴药物治疗:现状与未来展望》。

IF 2.9 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Clinics in liver disease Pub Date : 2024-08-01 DOI:10.1016/j.cld.2024.06.014
Timothy R. Morgan MD
{"title":"酒精相关肝炎的新兴药物治疗:现状与未来展望》。","authors":"Timothy R. Morgan MD","doi":"10.1016/j.cld.2024.06.014","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10489,"journal":{"name":"Clinics in liver disease","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis\",\"authors\":\"Timothy R. Morgan MD\",\"doi\":\"10.1016/j.cld.2024.06.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10489,\"journal\":{\"name\":\"Clinics in liver disease\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinics in liver disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S108932612400062X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinics in liver disease","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S108932612400062X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在酒精相关肝炎的初步试验中,有几种治疗方法显示出了疗效。在一项 II 期试验中,白介素-22 改善了终末期肝病模型评分和转氨酶。在美国或欧洲的一项多中心 II 期试验中,内源性胆固醇衍生物 larsucosterol 可改善疗效。抗氧化剂 N-乙酰半胱氨酸和美他多辛在大型试验中提高了存活率。印度的试验报告称,粒细胞集落刺激因子可提高存活率,接受粪便微生物群转移治疗的患者的预后也有所改善。转化研究表明,用噬菌体治疗溶胞性粪肠球菌可减轻肝损伤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinics in liver disease
Clinics in liver disease GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
5.30
自引率
0.00%
发文量
79
审稿时长
>12 weeks
期刊介绍: A perfect source to consult for those in the fields of gastroenterology and hepatology, Clinics in Liver Disease provides answers to clinical questions, information on the latest diagnostic methods and treatments, and numerous clinical images. Published quarterly—in February, May, August, and November—each issue offers in-depth reviews that focus on the liver and biliary system.
期刊最新文献
Contents Alcohol-Associated Liver Disease: Treatment and Prevention Treatment of Alcohol Use Disorder Alcohol-Associated Liver Disease Copyright
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1